Background: Orthopedic surgery is more and more frequent in the older patients and is associated with a high mortality rate. Although serum procalcitonin levels are associated with prognosis in young adults, data are still lacking in the elderly population, and especially after surgery. The main objective of this study was to determine the prognostic value of procalcitonin levels in a large geriatric orthopedic population, and we compared it with clinical variables and biomarkers. Methods: This is a prospective study including patients admitted in our dedicated geriatric postoperative unit, after orthopedic surgery with immediate postoperative measured procalcitonin levels. Collected data included age, sex, medical history, functional status (activities of daily living [ADL]), fracture type, Cumulative Illness Rating scale (CIRS), postoperative complications, and biological data. The primary endpoint was the 30-day mortality. Results: 436 patients (age 85 ± 6 years) were included. Hip fracture surgery was the most frequent (n = 310; 71%), and the 30-day mortality rate was 6.9%. Compared with C-reactive protein (CRP), albumin, CIRS, and ADL, procalcitonin had the highest area under the receiver operating characteristic curve for predicting 30-day mortality (0.74; 95% CI: 0.70-0.78). Using a cutoff at 1 µg/L, procalcitonin was more specific than CIRS to predict 30-day mortality (92 vs 77%; p < .001). In a multivariable analysis, procalcitonin level higher than 0.39 µg/L is a significant predictor of mortality within 30 days (odds ratio 3.84; 95% CI: 1.61-9.14, p = .002). Conclusion: Elevated procalcitonin values were strongly and significantly associated with mortality within 30 days in older patients after orthopedic surgery.
Orthopedic surgery, particularly in elderly patients, often leads to inflammation, dehydration, malnutrition, and infectious and cardiovascular complications. Several clinical factors have been associated with orthopedic postoperative mortality, for example, age, postoperative complications, and comorbidities (5, 9) . Compared with elective total hip replacement, emergency hip fracture surgery is associated with a sixfold increased risk of in-hospital mortality (10) . For patients with hip fracture, clinical and biological factors have been associated with mortality, including postfracture complications, sex, comorbidities (8) , postoperative complications, low albumin (11) , high creatinine (12) , elevated troponin (13) , or proinflammatory cytokines (14) . Search for clinically relevant biomarkers to determine prognosis and optimize management is still of major interest. Procalcitonin is a precursor of calcitonin. Its production is triggered by acute conditions, such as sepsis (15) , trauma (16) , or surgery (17) . Interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) are two proinflammatory cytokines in procalcitonin production (18) and are predictive of postoperative mortality after a hip fracture in the elderly population (14) . Nevertheless, these cytokines are not routinely measured as opposed to procalcitonin. Procalcitonin has been previously associated with all-cause and cancer mortality in apparently healthy men (19) and has a prognostic value in myocardial infarction, cancer, and sepsis patients (20) (21) (22) . Increased level of procalcitonin is predictive of early mortality after cardiac surgery (17) and of fatal sepsis after soft tissue surgery (23) . Regarding routine biomarkers, elevated serum procalcitonin values are associated with postoperative complications in trauma patients as opposed to C-reactive protein (CRP) (19) .
Data are still lacking regarding the prognostic value of procalcitonin, especially after surgery. Our main objective was to evaluate prognostic value of procalcitonin in a large number of elderly patients after orthopedic surgery, and we also compared it with clinical variables and biomarkers.
Materials and Methods
This study was carried out in a 10-bed perioperative geriatric unit (Unit for Peri-Operative Geriatric Care, UPOG) in a tertiary universitary teaching hospital. Only patients recovering from emergency orthopedic surgery, mostly hip fracture repair, board this unit. This study was approved by the ethics committee (CPP Pitié-Salpêtrière, Paris, France) and because the study was observational, informed consent was waived. The database was recorded to the French National Commission for Computing and Liberty (CNIL, Paris, France). Detailed methodology has been previously reported for patients with hip fracture (24) . The database was created in 2009 and data acquisition has been prospective since then. The statistical plan of the study was decided before the statistical analysis.
Patients
From July 2009 to July 2013, all consecutive patients admitted to our unit (n = 527) were evaluated for eligibility. Patients were included if they had undergone orthopedic surgery, were 70 years of age or older, and had been tested for serum procalcitonin within 3 days after surgery. Patients were excluded if procalcitonin measurement was lacking.
Data Collection
Data collected prospectively included age, sex, previous medical history, fracture type and surgical treatment, and duration of surgery (24) . Associated comorbidities were carefully reviewed, and their severity was assessed using the Cumulative Illness Rating scale (CIRS), a validated scale for elderly population, in which concurring medical conditions are weighted from 0 to 4 in 13 main systems (25) . According to Zekry and colleagues, the CIRS improved hospital discharge planning for elderly patients with acute disease (26) . Functional status was assessed by the Activities of Daily Living (ADL) scale. Blood samples were drawn routinely within the first 3 days after surgery. CRP was measured by automatic laser nephelometry (BN 100 analyzer; Boehring Dade, Marburg, Germany), normal values were less than 5 mg/L, and the coefficient of variation of the measurement was less than 5%. Pre-and post-operative hemoglobin level, postoperative serum creatinine, estimated creatinine clearance using the Cockroft formula, and serum albumin level were recorded. Chronic renal failure was defined as an estimated Cockcroft creatinine clearance ≤60 mL/min, malnutrition was defined as an albumin value ≤35 g/L, and anemia was defined using the WHO definition, as previously reported (24) .
Procalcitonin Measurement
Procalcitonin measurement was routinely performed within the first 3 days after surgery. Procalcitonin concentrations were analyzed using a sandwich immunoassay based on time resolved amplified cryptate emission (TRACE) measurement (Kryptor analyzer; B.R.A.H.M.S. Thermofisher, Hennigsdorf, Germany) whose detection limit was 0.08 µg/L. Normal values were less than 0.5 µg/L, and the coefficient of variation of the measurement was less than 5%.
Outcomes and Follow-up
All medical and surgical complications occurring during UPOG stay were prospectively recorded, as previously reported (24) . Infection was diagnosed by a panel of experts unaware of procalcitonin values, according to guidelines previously described (27) . Patients were monitored until death or 30 days after admission (24) .
Objectives and Endpoint
Our main objective was to evaluate prognostic value of procalcitonin, and we also compared it with clinical variables and biomarkers. The endpoint was mortality within 30 days.
Statistical Analysis
Continuous variables are presented as mean ± SD or median (interquartile range) and categorical variables as numbers and percentages. Levene's test for equality of variances was used to test variables for normality. Continuous variables were compared using Student's t test (if normal distribution) or Kruskal-Wallis test and categorical variables using Pearson's chi-square test.
Receiver operating characteristic (ROC) curve analysis was performed to assess predictive value of biomarkers and their optimal threshold values, determined by the Youden index (28) . We assessed the sensitivity and specificity and positive and negative predictive values (all with their 95% confidence intervals [95% CIs], calculated with the Wilson's score with correction of continuity for thresholds). All evaluated biomarkers were compared with CIRS.
Finally, a forward logistic regression was performed to assess variables associated with death. For this analysis, procalcitonin, CRP, serum albumin, and ADL were evaluated as categorical variables based on the optimum cutoff point previously determined by ROC analysis. We adopted a conservative approach and only included in the model preoperative variables that were significant in the univariate analysis (p value < .10). The discriminant power of the model was evaluated by the c statistic (concordance index) and its calibration by the Hosmer-Lemeshow test.
All tests were two tailed, and a p value less than .05 was considered significant. Statistical analysis was performed using MedCalc 10.3.2.0 for Windows (MedCalc Software, Mariakerke, Belgium).
Results
From July 2009 to July 2013, 527 patients were assessed for the study, and 436 (83%) were included because they were tested for procalcitonin level within 3 days of admission.
Baseline characteristics are presented in Table 1 . Four hundred and six patients (93%) had an emergency surgical procedure Notes: Results are expressed in mean ± SD or median (IQR) or number (percentage). ADL = activity of daily living; CAD = coronary artery disease; CIRS = Cumulative Illness Rating Scale; COPD = chronic obstructive pulmonary disease; CRP: C-reactive protein; ICU = intensive care unit. and only 7% had scheduled surgery. Types of emergency fractures included hip (n = 310; 71%), femoral shaft (n = 25; 5.7%), knee (n = 9; 2.1%), ankle (n = 18; 4.1%), shoulder (n = 5; 1.1%), humeral shaft (n = 18; 4.1%), elbow (n = 6; 1.4%), wrist (n = 11; 2.5%), spine (n = 9; 2.1%), and other (n = 4, 0.9%) fractures. Thirty patients (6.9%) presented multiple fractures. Types of scheduled surgery included elective total hip replacement (n = 18, 4.1%), elective total knee replacement (n = 3, 0.7%), spine surgery (n = 8, 1.8%), and elbow surgery (n = 1, 0.2%).
During the study period, 30 (6.9%) patients died within 30 days of postadmission. They had a significantly lower functional status and were more prone to heart or chronic kidney failure upon admission. During hospital stay, they encountered more swallowing disorders, infections, acute cardiac failure, pressure ulcers, and intensive care unit (ICU) transfers (Table 1) .
Compared with alive patients at 30 days, deceased patients had higher levels of procalcitonin, CRP, and serum creatinine and lower serum albumin, postoperative hemoglobin, and estimated creatinine clearance values (Table 1) .
AUCs for Predicting 30-Day Mortality
Procalcitonin ROC curve had the highest area under the curve (AUC) for predicting outcome (0.74; 95% CI: 0.70-0.78), and this AUC was significantly higher than that of CRP (0.61; 95% CI: 0.56-0.65, p = .002). There was no significant difference when comparing the AUC of procalcitonin with that of Cumulative Illness Rating scale (CIRS; 0.61; 95% CI: 0.57-0.66, p = . 
Performances of Biomarkers and Clinical Markers to Predict 30-Day Mortality
Optimal thresholds for procalcitonin (>0.39 µg/L), CRP (>80 mg/L), CIRS (>11), ADL (<6), creatinine (>81 µmol/L), postsurgery hemoglobin (≤9.3 mg/dL), and albumin (≤24 g/L) were determined by ROC analysis. When using these thresholds (Table 2) , the sensitivity and specificity of procalcitonin to predict 30-day mortality were not significantly different from CIRS. However, high levels of procalcitonin (>1 µg/L) better predicted 30-day mortality than CIRS.
Multivariate Analysis
All eligible variables from univariable analysis were included in a logistic regression model (Table 3) . In multivariable analysis, procalcitonin remained an independent predictor of 30-day mortality, regardless of the threshold considered. Similarly, albumin and creatinine remained independent predictors of 30-day mortality. In contrast, CRP, CIRS, and ADL did not significantly contribute to the prediction. The model was discriminant (c statistic at 0.85) and fitted well (significance of the Hosmer-Lemeshow test = 0.71). These results were not modified after exclusion of scheduled surgeries, when our analysis only included emergency patients (n = 406) (procalcitonin > 0. 39 
Discussion
Because the prognosis of acute surgical or medical conditions remains challenging in elderly patients, biomarkers in the clinical Notes: *The different CRP and procalcitonin thresholds were evaluated alternatively. † Variable found not to significantly contribute to the prediction; the software did not include it in the model. ADL = activity of daily living; CIRS = Cumulative Illness Rating Scale; CRP = C-reactive protein. Notes: *Optimal threshold. ADL = activity of daily living; CIRS = Cumulative Illness Rating Scale; CRP = C-reactive protein; Hb = hemoglobin; NPV = negative predictive value; PPV = positive predictive value. management of these patients are raising. We found that procalcitonin is a strong predictive biomarker associated with the short-term mortality after orthopedic surgery in the elderly population. First, using AUC, procalcitonin was more predictive of 30-day mortality than CRP. Second, high levels of procalcitonin (>1 µg/L) have a stronger specificity than CIRS. Last, a high level of procalcitonin was associated with 30-day mortality rate in our multivariate analysis, whereas CIRS, ADL, and CRP were not. Although we have been working in a fairly small cohort (30 deaths in the study), procalcitonin appeared to be an interesting biomarker to better assess 30-day prognosis in the elderly patients after orthopedic surgery.
Procalcitonin has been previously suggested as a predictor of postoperative complications and mortality following surgery, mostly in nongeriatric populations. After cardiac transplantation, an increase in procalcitonin level was more frequently reported in patients with postoperative complications, which was associated with early mortality (17) . After cardiopulmonary bypass, procalcitonin was found to be a better marker of bacterial infection than CRP, white blood cell count, and IL-6 and IL-8; procalcitonin level was significantly higher in patients who died than in the survival group (29) . In young patients with severe trauma, procalcitonin levels were associated with mortality (30) . The value of procalcitonin for prognosis was also demonstrated in critical care: Several ICU studies have shown that procalcitonin clearance and/or decrease within the first days after onset of sepsis or septic shock was associated with survival (22,31). More generally, procalcitonin was found predictive of mortality (all-cause and cancer associated) in apparently healthy men in a large prospective cohort (19) .
In contrast, data are scarce regarding procalcitonin in the elderly population. In elderly patients with community-acquired pneumonia, procalcitonin levels were associated with pneumonia intensity but not with mortality (32) . Elderly patients admitted in acute geriatric care unit with infection and a normal procalcitonin level had lower heart rate, lower white blood cell counts and CRP levels, and higher creatinine clearance, suggesting less intense infection (33) .
Little is known of the prognostic value of procalcitonin after surgery in elderly patients. Procalcitonin as a predictor of 30-day mortality is a breakthrough, as well as its greater accuracy in predicting short-term mortality in comparison with CRP. This is consistent with previous studies in critical care patients for which an increase in procalcitonin level was predictive of bloodstream invasion, septic shock, organ failure, and mortality and carried a greater prognostic significance in the course of infectious disease than CRP (15, 34) . In another recent study on hip fracture, perioperative CRP level was not predictive of long-term survival (35) . In our study, serum creatinine >81 µmol/L and serum albumin ≤24 g/L were also predictive of 30-day mortality, with larger OR than procalcitonin. These results were in agreement with previous data after hip fracture surgery for serum creatinine (12) and serum albumin (11) and after noncardiac surgery for both biomarkers (5) .
Several mechanisms could explain the predictive value of procalcitonin after orthopedic surgery in the elderly population. First, aging is associated with a low grade inflammation called "inflammaging" (36) . Moreover, organ dysfunction and high level of proinflammatory cytokines are closely correlated (37, 38) . Patients with more severe systemic inflammation after surgery have probably a higher risk of organ dysfunction. Second, patients with higher procalcitonin levels might have been prone to more frequent postoperative infectious disease.
In our study, clinical factors, such as morbidity and functional status, were not associated with 30-day mortality. This is unlike previous reports, in which preoperative multiple comorbidities, poor activities of daily living, and a high Charlson comorbidity score upon admission were strong predictors of mortality after hip fracture repair (39, 40) . It is important to mention that most of these studies focus on mortality after a longer term (ie, 6-12 months) (24, 39, 40) , as opposed to 30 days in our study. Clinical factors could therefore be related more to mortality at a longer term. Further studies should assess procalcitonin prognostic value over longer periods of time.
Patients will benefit from procalcitonin as a predictive factor, especially in the postoperative period, when inflammation, infection, and delirium frequently hamper clinical assessment. High levels of procalcitonin could help spot vulnerable patients and allow closer check-ups and adapted care to avoid an unfavorable outcome.
Our study has several strengths. First, it is the first to assess the prognostic value of procalcitonin in an elderly population after orthopedic surgery. Second, it is prospective and the number of patients lost to follow-up was limited. Finally, the large number of emergency orthopedic patients with high levels of procalcitonin highlights an acute condition associated with mortality. Likewise, procalcitonin could reflect the severity of underlying conditions, such as infection, responsible for the sixfold increase in mortality risk for emergency surgery compared with elective surgery (10) .
Our study has several limitations. First, the number of events was low (n = 30). However, despite this small sample, we found a significant correlation between high levels of procalcitonin and mortality in a multivariate analysis. This strong correlation should be confirmed with a bigger sample. Lastly, we did not evaluate the prognostic value of procalcitonin on the long-term mortality.
In conclusion, procalcitonin is a strong predictive biomarker associated with the short-term mortality after orthopedic surgery in the elderly population. The predictive value of procalcitonin is higher than that of CIRS, ADL, and CRP.
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